highly significantP < 0.001
Specifically, the use of DIBH resulted in a highly significant decrease in the mean and maximum doses of the heart, the LAD artery, and the ipsilateral lung exposure ( P < 0.001), for both normal fractionation (NF) and hypofractionation (HF) treatment plans.